Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

Cisplatin/gemcitabine association has been a standard of care for first-line regimen in advanced biliary tract cancer nevertheless oxaliplatin/gemcitabine regimen is frequently preferred. Because comparative effectiveness in clinical outcomes of cisplatin- versus oxaliplatin-containing chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiteni, Frédéric, Nguyen, Thierry, Vernerey, Dewi, Paillard, Marie-Justine, Kim, Stefano, Demarchi, Martin, Fein, Francine, Borg, Christophe, Bonnetain, Franck, Pivot, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298376/
https://www.ncbi.nlm.nih.gov/pubmed/25111859
http://dx.doi.org/10.1002/cam4.299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298376/
https://www.ncbi.nlm.nih.gov/pubmed/25111859
http://dx.doi.org/10.1002/cam4.299

Ejemplares similares